Genome Editing Market: By Techniques, By Application, By End Users and Region Forecast 2019 - 2030

Genome Editing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Techniques (CRISPR-Cas9, TALENs, ZFNs, Homing Endonucleases, PASTE, Prime Editing Systems, and Others), By Application (Engineering Cell Lines and Organisms, Synthetic Biology and Genome-Scale Engineering, Therapeutic Genome Editing, Diagnostics, Drug Discovery and Development, and Others), By End Users (Biotechnology and Pharmaceutical Companies, Academic and Research Organizations, Contract Research Organizations, and  Others) and Region Forecast 2019 - 2030

Genome Editing Market size was valued at US$ 5,648.3 Million in 2023 and is expected to grow at a CAGR of 12.8% from 2024-2030. The market is a fast-growing sector within the field of Biotechnology, offering revolutionary tools and techniques for editing the genetic makeup of the living organism to address various challenges in healthcare, agriculture, and other industries. According to the National Human Genome Research Institute, around 350 million people on earth have a rare disorder, which has been identified in fewer than 200,000 people. About 80% of these uncommon ailments are genetically based, and 95% don't even have one FDA-approved medication. This rising prevalence of rare genetic disorders, congenital disorders, and chronic diseases is driving the market.

Moreover, Advancements in genome editing techniques coupled with rising demand for personalized medicine and targeted therapies are accelerating the market further. However, ethical and regulatory concerns, off-target effects and safety concerns, delivery challenges, and high development and implementation costs are some of the factors that restrain the growth of the market. Furthermore, the market is witnessing several key trends including the development of novel genome editing tools, advancements in genome editing tool delivery systems, and the rise of therapeutic application.

The growing interest and investment in genome editing research contribute to market growth and several companies are participating in launching new tools and techniques. In May 2023, Mission Bio introduced a new end-to-end product, Tapestri Genome Editing Solution, for the analysis of genome editing. In March 2021, Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, launched its rhAmpSeq CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.

Genome Editing Market Key Developments

  • In May 2023, Pairwise, a health-focused food and agriculture company launched the Fulcrum Platform, which is built on proprietary CRISPR technology along with other custom gene editing tools
  • In September 2022, global genomics solutions provider, Integrated DNA Technologies (IDT) has expanded access to its customization options for the Alt-R Custom CRISPR gRNA Libraries.

Genome Editing Market Summary

Study Period

2024– 2030

Base Year

2023

CAGR

12.8%

Largest Market

North America

Fastest Growing Market

Asia pacific

Genome Editing Market Dynamics

The genome editing market is expected to rise with the increasing frequency of genetic disorders and chronic diseases, including albinism, Angelman syndrome, heart disease, Huntington’s disease, etc. Moreover, growing investment in genome editing research and improvements in innovative genome editing technologies like CRSPR-Cas9, TALENs, etc. aid in the advancement of the market as well as open up numerous opportunities for growth over the forecast years. In addition to the opportunities, the genome editing market confronts difficulties that need to be overcome, including genome editing in humans, off-target consequences, and the requirement for further long-term safety studies. Overall, the genome editing market is poised for significant growth and innovation. Ongoing research, collaborations, and advancements in genome editing technologies will continue to drive the market forward, enabling breakthroughs in healthcare, agriculture, and various other sectors.

Genome Editing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024– 2030

Market CAGR

12.8%

By Techniques

  • CRISPR-Cas9
  • TALENs
  • ZFNs
  • Homing Endonucleases
  • PASTE
  • Prime Editing Systems
  • Others

By Application

  • Engineering Cell Lines and Organisms
  • Synthetic Biology and Genome-Scale Engineering
  • Therapeutic Genome Editing
  • Diagnostics
  • Drug Discovery and Development
  • Others

By End User

  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Organizations
  • Contract Research Organisations
  • Others

Key Features of the Report

  • The genome editing market report provides granular level information about the market size, regional market share, historic market (2019-2023)and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

 

Download Free Sample Report

Frequently Asked Questions

The global genome editing market was valued at US$ 5,648.3 Million in 2023 and is expected to grow at a CAGR of 12.8% over 2024-2030.

Therapeutic applications, agricultural and livestock applications, research and drug discovery, development of gene therapies, expansion of targeted genetic modifications, and development of delivery systems are some of the potential opportunities for companies to enhance their revenue over the forecast years.

Expansion of CRISPR- Cas9 technology, development of novel genome editing tools, advancements in delivery techniques, and industrial application in the agriculture and biotechnology are some of the major trends in the genome editing market.

Lonza Group Ltd., Editas Medicine, Inc, Genscript Biotech Corporation, Eurofins Scientific, Perkinelmer, Inc., Merck Kgaa, Integrated Dna Technologies, Thermo Fisher Scientific, Inc, Crispr Therapeutics Ag, Danaher Corporation, Aglient Technologies, Inc., Pairwise, Mission Bio, Takara Bio, Inc., OriGene Technologies, Inc., Bio-Rad Laboratoies, Inc., Qiagen N.V. are some of the key players in the genome editing market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Genome Editing Market Introduction 
2.1.Global Genome Editing Market  - Taxonomy
2.2.Global Genome Editing Market  - Definitions
2.2.1.Techniques
2.2.2.Application
2.2.3.End Users
2.2.4.Region
3. Global Genome Editing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Genome Editing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Genome Editing Market  By Techniques, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. CRISPR-Cas9
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. TALENs
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. ZFNs
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Homing Endonucleases
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. PASTE
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Prime Editing Systems
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6. Global Genome Editing Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Engineering Cell Lines and Organisms
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Synthetic Biology and Genome-Scale Engineering
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Therapeutic Genome Editing
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Diagnostics
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Drug Discovery and Development
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7. Global Genome Editing Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Biotechnology and Pharmaceutical Companies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Academic and Research Organizations
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Contract Research Organisations
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Genome Editing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Techniques Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.CRISPR-Cas9
9.1.2.TALENs
9.1.3.ZFNs
9.1.4.Homing Endonucleases
9.1.5.PASTE
9.1.6.Prime Editing Systems
9.1.7.Others
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Engineering Cell Lines and Organisms
9.2.2.Synthetic Biology and Genome-Scale Engineering
9.2.3.Therapeutic Genome Editing
9.2.4.Diagnostics
9.2.5.Drug Discovery and Development
9.2.6.Others
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Biotechnology and Pharmaceutical Companies
9.3.2.Academic and Research Organizations
9.3.3.Contract Research Organisations
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Techniques Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.CRISPR-Cas9
10.1.2.TALENs
10.1.3.ZFNs
10.1.4.Homing Endonucleases
10.1.5.PASTE
10.1.6.Prime Editing Systems
10.1.7.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Engineering Cell Lines and Organisms
10.2.2.Synthetic Biology and Genome-Scale Engineering
10.2.3.Therapeutic Genome Editing
10.2.4.Diagnostics
10.2.5.Drug Discovery and Development
10.2.6.Others
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Biotechnology and Pharmaceutical Companies
10.3.2.Academic and Research Organizations
10.3.3.Contract Research Organisations
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Techniques Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.CRISPR-Cas9
11.1.2.TALENs
11.1.3.ZFNs
11.1.4.Homing Endonucleases
11.1.5.PASTE
11.1.6.Prime Editing Systems
11.1.7.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Engineering Cell Lines and Organisms
11.2.2.Synthetic Biology and Genome-Scale Engineering
11.2.3.Therapeutic Genome Editing
11.2.4.Diagnostics
11.2.5.Drug Discovery and Development
11.2.6.Others
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Biotechnology and Pharmaceutical Companies
11.3.2.Academic and Research Organizations
11.3.3.Contract Research Organisations
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Techniques Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.CRISPR-Cas9
12.1.2.TALENs
12.1.3.ZFNs
12.1.4.Homing Endonucleases
12.1.5.PASTE
12.1.6.Prime Editing Systems
12.1.7.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Engineering Cell Lines and Organisms
12.2.2.Synthetic Biology and Genome-Scale Engineering
12.2.3.Therapeutic Genome Editing
12.2.4.Diagnostics
12.2.5.Drug Discovery and Development
12.2.6.Others
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Biotechnology and Pharmaceutical Companies
12.3.2.Academic and Research Organizations
12.3.3.Contract Research Organisations
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Genome Editing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Techniques Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.CRISPR-Cas9
13.1.2.TALENs
13.1.3.ZFNs
13.1.4.Homing Endonucleases
13.1.5.PASTE
13.1.6.Prime Editing Systems
13.1.7.Others
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Engineering Cell Lines and Organisms
13.2.2.Synthetic Biology and Genome-Scale Engineering
13.2.3.Therapeutic Genome Editing
13.2.4.Diagnostics
13.2.5.Drug Discovery and Development
13.2.6.Others
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Biotechnology and Pharmaceutical Companies
13.3.2.Academic and Research Organizations
13.3.3.Contract Research Organisations
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Lonza Group Ltd.
14.2.2.Editas Medicine, Inc
14.2.3.Genscript Biotech Corporation
14.2.4.Eurofins Scientific
14.2.5.Perkinelmer, Inc.
14.2.6.Merck Kgaa
14.2.7.Integrated Dna Technologies
14.2.8.Thermo Fisher Scientific, Inc
14.2.9.Crispr Therapeutics Ag
14.2.10.Danaher Corporation
14.2.11.Aglient Technologies, Inc.
14.2.12.Pairwise
14.2.13.Mission Bio
14.2.14.Takara Bio, Inc.
14.2.15.OriGene Technologies, Inc.
14.2.16.Bio-Rad Laboratoies, Inc.
14.2.17.Qiagen N.V.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Lonza Group Ltd.
  • Editas Medicine, Inc
  • Genscript Biotech Corporation
  • Eurofins Scientific
  • Perkinelmer, Inc.
  • Merck Kgaa
  • Integrated Dna Technologies
  • Thermo Fisher Scientific, Inc
  • Crispr Therapeutics Ag
  • Danaher Corporation
  • Aglient Technologies, Inc.
  • Pairwise
  • Mission Bio
  • Takara Bio, Inc.
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratoies, Inc.
  • Qiagen N.V.

Related Industry Reports